Biotech

All Articles

FibroGen lays off 75% of US personnel as resource fails 2 even more tests

.FibroGen is drastically reorganizing its organization, giving up 75% of its own united state person...

Tracon relax weeks after injectable PD-L1 prevention stop working

.Tracon Pharmaceuticals has actually determined to relax operations full weeks after an injectable i...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is betting $400 million in biobucks that a bispecific antibody-drug conjugate (A...

Takeda takes $140M loss on stopped working epilepsy medication, promotes FDA operate

.Our experts actually understand that Takeda is expecting to locate a course to the FDA for epilepsy...

VBI Injections declare bankruptcy, seeks possession sale

.Immunology biotech VBI Injections is drifting precariously near to the defining moment, along with ...

Celldex anti-cKIT antibody minimize colonies in another stage 2 study

.It is actually difficult to muscle in on a room as affordable as immunology, however Celldex Therap...

Boehringer provides to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapies and a preclinical immune ch...

Ventyx's last resort for inflamed med ends in Crohn's failure

.Ventyx Biosciences' Crohn's health condition medication performed certainly not aid people achieve ...

Cognition's phase 2 SHINE information stain Alzheimer's prospect

.Knowledge Rehabs' period 2 luster test has actually taken a few of the gloss off the Alzheimer's il...

BMS centers bispecific months after submitting to work phase 3 test

.Bristol Myers Squibb has actually had a whiplash change of mind on its own BCMA bispecific T-cell e...